Differences in Protein Expression and Gene Amplification of Cyclins between Colon and Rectal Adenocarcinomas
Author(s) -
Rolf Aamodt,
Kristín Jónsdóttir,
Solveig Norheim Andersen,
Johan Bondi,
Geir Bukholm,
Ida Bukholm
Publication year - 2009
Publication title -
gastroenterology research and practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 45
eISSN - 1687-630X
pISSN - 1687-6121
DOI - 10.1155/2009/285830
Subject(s) - cyclin d1 , cyclin , colorectal cancer , cyclin d , medicine , rectum , cyclin a2 , cyclin d3 , cancer research , gene expression , cyclin e , gene duplication , gene , cell cycle , cancer , biology , genetics
Adenocarcinomas of rectum and colon may be different with regard to the cellular biological basis for cancer development. A material of 246 rectal cancers removed surgically at Akershus University Hospital in the years 1992–2000 was investigated and was compared to a material of 219 colon cancers operated on at Akershus University Hospital during the years 1988, 1990 and 1997–2000. There were highly significant differences between the rectal and the colon cancers in the protein expression of cyclin D1, cyclin D3, cyclin E, nuclear β -catenin, and c-Myc and in gene amplification of cyclin A2, cyclin B1, cyclin D1, and cyclin E. Gene amplification and protein expression in the rectal cancers correlated significantly for the cyclins B1, D3, and E. A statistically significant relation was observed between overexpression of cyclin A2 and local relapse of rectal carcinomas, as higher expression of cyclin A2 was associated with lower local recurrence rate.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom